melatonin has been researched along with Chronic Hepatitis B in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nephrotoxicity is a dose-limiting side effect of long-term use of tenofovir, a reverse transcriptase inhibitor that is used for the treatment of HIV infection and chronic hepatitis B infection." | 4.02 | Melatonin protects against tenofovir-induced nephrotoxicity in rats by targeting multiple cellular pathways. ( Abraham, P; Isaac, B; Ramamoorthy, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramamoorthy, H | 1 |
| Abraham, P | 1 |
| Isaac, B | 1 |
1 other study available for melatonin and Chronic Hepatitis B
| Article | Year |
|---|---|
Melatonin protects against tenofovir-induced nephrotoxicity in rats by targeting multiple cellular pathways.
Topics: Animals; Antiviral Agents; Hepatitis B, Chronic; HIV Infections; Humans; Male; Melatonin; Metabolic | 2021 |